{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:04:12Z","timestamp":1793329452050,"version":"4.5.0"},"reference-count":62,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Drug-coated balloons (DCBs) have transformed percutaneous coronary intervention (PCI) by delivering antiproliferative drugs directly to the arterial wall, offering a stent-less approach that mitigates the risks associated with permanent metallic implants. Initially developed for in-stent restenosis (ISR), DCBs have demonstrated robust efficacy in reducing neointimal hyperplasia and target lesion revascularization (TLR) rates across diverse coronary lesions, including small vessel disease (SVD), de novo lesions, and complex anatomies such as bifurcation lesions. Paclitaxel-coated balloons have long been the cornerstone of DCB therapy due to their established clinical outcomes, but sirolimus-coated balloons are emerging as a promising alternative with potentially superior safety profiles and sustained drug release. The pharmacological mechanism of DCBs relies on rapid drug transfer during brief balloon inflation, achieving high local concentrations without residual foreign material. Landmark trials, such as BASKET-SMALL 2, RESTORE SVD, and AGENT IDE, have demonstrated comparable or non-inferior outcomes of DCBs versus drug-eluting stents (DESs) in specific settings, with lower rates of stent thrombosis and shorter dual antiplatelet therapy (DAPT) requirements. Despite these advances, challenges persist, including optimizing drug formulations, ensuring uniform delivery, and addressing calcified lesions. Ongoing research into novel coatings, dual\u2013drug systems, and artificial intelligence (AI)-guided interventions is poised to redefine PCI strategies. This review provides a comprehensive analysis of drug-coated balloon (DCB) angioplasty, not limited to specific clinical scenarios such as in-stent restenosis, small vessel disease, or bifurcation lesions, highlighting their transformative role in coronary artery disease (CAD) management. Instead, it addresses the full spectrum of pharmacological principles, mechanisms of action, clinical indications, comparative efficacy across various coronary artery disease contexts, and future directions of DCBs.<\/jats:p>","DOI":"10.3390\/medicina61081470","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T14:24:28Z","timestamp":1755267868000},"page":"1470","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Coronary Angioplasty with Drug-Coated Balloons: Pharmacological Foundations, Clinical Efficacy, and Future Directions"],"prefix":"10.3390","volume":"61","author":[{"given":"Valentin","family":"Chioncel","sequence":"first","affiliation":[{"name":"Department of Cardiology, University of Medicine and Pharmacy Carol Davila, 050474 Bucharest, Romania"},{"name":"Emergency Clinical Hospital Dr. Bagdasar-Arseni, 041915 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavius","family":"Gherasie","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Medicine and Pharmacy Carol Davila, 050474 Bucharest, Romania"},{"name":"Emergency Clinical Hospital Dr. Bagdasar-Arseni, 041915 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandru","family":"Iancu","sequence":"additional","affiliation":[{"name":"Emergency Clinical Hospital Dr. Bagdasar-Arseni, 041915 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1742-3128","authenticated-orcid":false,"given":"Anamaria-Georgiana","family":"Avram","sequence":"additional","affiliation":[{"name":"Emergency Clinical Hospital Dr. Bagdasar-Arseni, 041915 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,15]]},"reference":[{"key":"ref_1","first-page":"61","article-title":"Nonoperative dilatation of coronary artery stenosis: Percutaneous transluminal coronary angioplasty","volume":"301","author":"Senning","year":"1978","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/j.jcin.2019.05.054","article-title":"Blinded Physiological Assessment of Residual Ischemia After Successful Angiographic Percutaneous Coronary Intervention: The DEFINE PCI Study","volume":"12","author":"Jeremias","year":"2019","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1161\/01.CIR.77.2.361","article-title":"Incidence of restenosis after successful coronary angioplasty: A time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months","volume":"77","author":"Serruys","year":"1988","journal-title":"Circulation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijcard.2022.05.024","article-title":"Bioresorbable stents: Is the game over?","volume":"361","author":"Gallinoro","year":"2022","journal-title":"Int. J. Cardiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM198703193161201","article-title":"Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty","volume":"316","author":"Sigwart","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJM199408253310802","article-title":"A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators","volume":"331","author":"Fischman","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJMoa012843","article-title":"Randomized Study with the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patients with de Novo Native Coronary Artery Lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization","volume":"346","author":"Morice","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(04)17275-9","article-title":"Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy","volume":"364","author":"McFadden","year":"2004","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/01.CIR.0000138929.71660.E0","article-title":"Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis","volume":"110","author":"Scheller","year":"2004","journal-title":"Circulation"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(12)61964-3","article-title":"Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): A randomised, open-label trial","volume":"381","author":"Byrne","year":"2013","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00392-014-0775-2","article-title":"Local paclitaxel induces late lumen enlargement in coronary arteries after balloon angioplasty","volume":"104","author":"Kleber","year":"2015","journal-title":"Clin. Res. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2217\/fca-2019-0009","article-title":"Drug-coated balloons for coronary artery disease: Current concepts and controversies","volume":"15","author":"Buccheri","year":"2019","journal-title":"Future Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(18)31719-7","article-title":"Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): An open-label randomised non-inferiority trial","volume":"392","author":"Jeger","year":"2018","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1016\/j.jcin.2020.08.035","article-title":"Drug-Coated Balloon Versus Drug-Eluting Stent for Small Coronary Vessel Disease: PICCOLETO II Randomized Clinical Trial","volume":"13","author":"Cortese","year":"2020","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_15","first-page":"e1322","article-title":"A randomised trial of sirolimus- versus paclitaxel-coated balloons for de novo coronary lesions","volume":"20","author":"Scheller","year":"2024","journal-title":"EuroIntervention"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Hu, W., and Jiang, J. (2022). Hypersensitivity and in-stent restenosis in coronary stent materials. Front. Bioeng. Biotechnol., 10.","DOI":"10.3389\/fbioe.2022.1003322"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Todd, M., Liu, L.B., Saul, J.M., and Yazdani, S.K. (2023). Pre-clinical investigation of liquid sirolimus for local drug delivery. Front. Cardiovasc. Med., 10.","DOI":"10.3389\/fcvm.2023.1184816"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"926","DOI":"10.4244\/EIJY14M08_12","article-title":"Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: The three-year results of the PEPCAD II ISR study","volume":"11","author":"Unverdorben","year":"2015","journal-title":"EuroIntervention"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0140-6736(19)31126-2","article-title":"Drug-coated balloon for treatment of de-novo coronary artery lesions in patients with high bleeding risk (DEBUT): A single-blind, randomised, non-inferiority trial","volume":"394","author":"Rissanen","year":"2019","journal-title":"Lancet"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3390\/futurepharmacol4040041","article-title":"Paclitaxel-Coated Versus Sirolimus-Coated Eluting Balloons for Percutaneous Coronary Interventions: Pharmacodynamic Properties, Clinical Evidence, and Future Perspectives","volume":"4","author":"Gurgoglione","year":"2024","journal-title":"Future Pharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1186\/s13063-021-05631-9","article-title":"Head-to-head comparison of sirolimus- versus paclitaxel-coated balloon angioplasty in the femoropopliteal artery: Study protocol for the randomized controlled SIRONA trial","volume":"22","author":"Ingwersen","year":"2021","journal-title":"Trials"},{"key":"ref_22","first-page":"4355","article-title":"Paclitaxel inhibits progression of mitotic cells to G1 phase by interference with spindle formation without affecting other microtubule functions during anaphase and telephase","volume":"54","author":"Long","year":"1994","journal-title":"Cancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1056\/NEJMoa061254","article-title":"Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter","volume":"355","author":"Scheller","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1161\/01.CIR.96.2.636","article-title":"Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery","volume":"96","author":"Axel","year":"1997","journal-title":"Circulation"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1161\/01.CIR.104.8.852","article-title":"Bench to bedside: The development of rapamycin and its application to stent restenosis","volume":"104","author":"Marx","year":"2001","journal-title":"Circulation"},{"key":"ref_27","first-page":"532","article-title":"Long term clinical outcome of sirolimus drug coated balloons in large coronary vessels","volume":"103","author":"Sciahbasi","year":"2024","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0140-6736(15)60657-2","article-title":"Percutaneous coronary interventional strategies for treatment of in-stent restenosis: A network meta-analysis","volume":"386","author":"Siontis","year":"2015","journal-title":"Lancet"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jcin.2017.10.024","article-title":"A Randomized Comparison of Paclitaxel-Eluting Balloon Versus Everolimus-Eluting Stent for the Treatment of Any In-Stent Restenosis: The DARE Trial","volume":"11","author":"Baan","year":"2018","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.jacc.2013.12.006","article-title":"A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: The RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: Paclitaxel-eluting balloon vs. everolimus-eluting stent)","volume":"63","author":"Alfonso","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1093\/eurheartj\/ehz594","article-title":"Paclitaxel-coated balloon angioplasty vs. drug-eluting stenting for the treatment of coronary in-stent restenosis: A comprehensive, collaborative, individual patient data meta-analysis of 10 randomized clinical trials (DAEDALUS study)","volume":"41","author":"Giacoppo","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1001\/jama.2024.1361","article-title":"Paclitaxel-Coated Balloon vs Uncoated Balloon for Coronary In-Stent Restenosis: The AGENT IDE Randomized Clinical Trial","volume":"331","author":"Yeh","year":"2024","journal-title":"JAMA."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.jcin.2022.03.024","article-title":"Biolimus-Coated Balloon in Small-Vessel Coronary Artery Disease: The BIO-RISE CHINA Study","volume":"15","author":"Xu","year":"2022","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1016\/j.jcin.2018.09.009","article-title":"Drug-Coated Balloon Versus Drug-Eluting Stent for Small-Vessel Disease: The RESTORE SVD China Randomized Trial","volume":"11","author":"Tang","year":"2018","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jcin.2022.01.012","article-title":"Treatment of Coronary De Novo Lesions by a Sirolimus- or Paclitaxel-Coated Balloon","volume":"15","author":"Ahmad","year":"2022","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.jcin.2019.04.016","article-title":"Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent in Acute Myocardial Infarction: The REVELATION Randomized Trial","volume":"12","author":"Vos","year":"2019","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1080\/17434440.2020.1831385","article-title":"Drug coated balloons and their role in bifurcation coronary angioplasty: Appraisal of the current evidence and future directions","volume":"17","author":"Rathore","year":"2020","journal-title":"Expert. Rev. Med. Devices."},{"key":"ref_38","first-page":"401","article-title":"Comparison of vessel healing in rabbit iliac arteries treated with sirolimus- and paclitaxel-coated balloons","volume":"17","author":"Aihara","year":"2024","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.4244\/EIJ-D-19-00723","article-title":"Bare metal or drug-eluting stent versus drug-coated balloon in non-ST-elevation myocardial infarction: The randomised PEPCAD NSTEMI trial","volume":"15","author":"Scheller","year":"2020","journal-title":"EuroIntervention."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0140-6736(23)02454-6","article-title":"Intravascular imaging-guided coronary drug-eluting stent implantation: An updated network meta-analysis","volume":"403","author":"Stone","year":"2024","journal-title":"Lancet"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.carrev.2020.07.036","article-title":"A HYbrid APproach Evaluating a DRug-Coated Balloon in Combination With a New-Generation Drug-Eluting Stent in the Treatment of De Novo Diffuse Coronary Artery Disease: The HYPER Pilot Study","volume":"28","author":"Ielasi","year":"2021","journal-title":"Cardiovasc. Revasc. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1093\/eurheartj\/ehz731","article-title":"Paclitaxel-coated balloons: A safe alternative to drug-eluting stents for coronary in-stent restenosis","volume":"41","author":"Lansky","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.jcin.2023.05.005","article-title":"Sirolimus-Coated Balloon in an All-Comer Population of Coronary Artery Disease Patients: The EASTBOURNE Prospective Registry","volume":"16","author":"Cortese","year":"2023","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/S0140-6736(20)32173-5","article-title":"Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial","volume":"396","author":"Jeger","year":"2020","journal-title":"Lancet"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.carrev.2024.05.027","article-title":"Drug-coated balloons for coronary artery disease: An updated review with future perspectives","volume":"69","author":"Bhogal","year":"2024","journal-title":"Cardiovasc. Revascularization Med."},{"key":"ref_46","unstructured":"SPACIOUS Investigators (2025). Sirolimus-coated versus paclitaxel-coated balloons in coronary bifurcation lesions: The SPACIOUS trial. Catheter. Cardiovasc. Interv., 105, 89\u201397."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.jcin.2024.12.024","article-title":"Sirolimus- vs Paclitaxel-Coated Balloon for the Treatment of Coronary In-Stent Restenosis: The SIBLINT-ISR Randomized Trial","volume":"18","author":"Liu","year":"2025","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.carrev.2021.04.013","article-title":"Comparison Between Sirolimus- and Paclitaxel-Coated Balloon for Revascularization of Coronary Arteries: The SIRPAC (SIRolimus-PAClitaxel) Study","volume":"28","author":"Cortese","year":"2021","journal-title":"Cardiovasc. Revascularization Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.avsg.2023.12.096","article-title":"MagicTouch PTA Sirolimus-Coated Balloon for Femoropopliteal and Below-the-Knee Disease: 3-Year Outcomes of the XTOSI Trial","volume":"106","author":"Choke","year":"2024","journal-title":"Ann. Vasc. Surg."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","article-title":"Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial","volume":"131","author":"Tepe","year":"2015","journal-title":"Circulation"},{"key":"ref_51","unstructured":"SELUTION SLR Investigators (2023). Sirolimus-eluting balloon in peripheral artery disease: Early results from, SELUTION SLR. J. Endovasc. Ther., 30, 178\u2013186."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/jamainternmed.2021.2738","article-title":"Longitudinal Assessment of Safety of Femoropopliteal Endovascular Treatment With Paclitaxel-Coated Devices Among Medicare Beneficiaries: The SAFE-PAD Study","volume":"181","author":"Secemsky","year":"2021","journal-title":"JAMA Intern. Med."},{"key":"ref_53","first-page":"544","article-title":"Sirolimus-coated balloon versus everolimus-eluting stent in de novo coronary artery disease: Rationale and design of the TRANSFORM II randomized clinical trial","volume":"100","author":"Greco","year":"2022","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e011245","DOI":"10.1161\/JAHA.118.011245","article-title":"Risk of Death Following Application of Paclitaxel-Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"7","author":"Katsanos","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Otto, S., D\u00edaz, V., Weilenmann, D., Cuculi, F., Nuruddin, A., Leibundgut, G., Alfonso, F., Ahmad, W., Pyxaras, S., and Rittger, H. (2023). Crystalline sirolimus-coated balloon (cSCB) angioplasty in an all-comers, patient population with stable and unstable coronary artery disease including chronic total occlusions: Rationale, methodology and design of the SCORE trial. BMC Cardiovasc. Disord., 23.","DOI":"10.1186\/s12872-023-03187-x"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.jcin.2020.02.043","article-title":"Drug-Coated Balloons for Coronary Artery Disease: Third Report of the International DCB Consensus Group","volume":"13","author":"Jeger","year":"2020","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/CIRCINTERVENTIONS.109.873703","article-title":"Drug-eluting balloon: The comeback kid?","volume":"2","author":"Waksman","year":"2009","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_58","first-page":"193","article-title":"Fractional flow reserve-guided paclitaxel-coated balloon treatment for de novo coronary lesions","volume":"88","author":"Shin","year":"2016","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1016\/j.jcin.2023.08.018","article-title":"Impact of Post-PCI FFR Stratified by Coronary Artery","volume":"16","author":"Collet","year":"2023","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1056\/NEJMoa1803538","article-title":"Five-Year Outcomes with PCI Guided by Fractional Flow Reserve","volume":"379","author":"Xaplanteris","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Medrano-Gracia, P., Ormiston, J., Webster, M., Beier, S., Ellis, C., Wang, C., Young, A.A., and Cowan, B.R. (2014). Construction of a coronary artery atlas from CT angiography. Lecture Notes in Computer Science, Springer.","DOI":"10.1007\/978-3-319-10470-6_64"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/eurheartj\/ehx458","article-title":"Clinical implications of three-vessel fractional flow reserve measurement in patients with coronary artery disease","volume":"39","author":"Lee","year":"2018","journal-title":"Eur. Heart J."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/8\/1470\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:28:40Z","timestamp":1760034520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/8\/1470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,15]]},"references-count":62,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["medicina61081470"],"URL":"https:\/\/doi.org\/10.3390\/medicina61081470","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,15]]}}}